
Zelluna Immunotherapy and Glycostem Therapeutics in licence deal
TCR cell therapy specialist Zelluna Immunotherapy (Oslo) and NK cell manufacturing specialist Glycostem Therapeutics BV (Oss) have entered into a...

Tacalyx GmbH raises €7m in seed funding
The financing was co-led by Boehringer Ingelheim Venture Fund and Kurma Partners. Idinvest Partners, High-Tech Gründerfonds (HTGF), coparion,...

Creoptix AG closes CHF8m financing round
The financing round was led by Swisscanto Invest by Zürcher Kantonalbank and joined by Waters Corporation as well as existing private investors....

Novo Nordisk enters haemophilia gene therapy field
Changes in the treatment standard of haemophilia A, such as Roche’s 2017 launch of Hemlibra, have put Novo Nordisk’s revenues (in the US$15.8bn...

ImCheck Therapeutics SAS raises €48m
The €48m financing was co-led by Pfizer Ventures, the venture capital arm of Pfizer Inc., and Bpifrance, with the new investors Wellington Partners,...

Boehringer and Zealand to advance obesity drug
Boehringer is collaborating with Danish Zealand Pharma on a long-acting amylin analogue (BI 473494) and a GLP-1/glucagon dual-acting agonist (BI...

Researchers unravel how ADEP antibiotics work
Fighting antimicrobial resistance has been named one of the prioritary goals by the World Health Organization (WHO). However, as the number of...